跳至主要内容
临床试验/JPRN-UMIN000034769
JPRN-UMIN000034769已完成未知

Vascular healing after the BioFreedom drug coated stent implantation in patients with acute coronary syndrome: HEAL-BioFreedom ACS study - HEAL-BioFreedom ACS study

Department of Cardiology, Osaka Police Hospital0 个研究点目标入组 30 人开始时间: 2018年11月5日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Pregnant and breastfeeding women 2. Patients expected not to comply with 1 month DAPT 3. Patients requiring a planned staged PCI procedure more than two weeks after the index procedure 4. Procedure planned to require non-study stents, or stand-alone POBA or stand-alone atherectomy 5. Active bleeding at the time of inclusion 6. Reference vessel diameter less than 2.25 or more than 4.0mm 7. Cardiogenic shock 8. Compliance with long-term single anti-platelet therapy unlikely 9. Known hypersensitivity or contraindication to aspirin, clopidogrel (or prasugrel, or ticagrelor if applicable), stainless steel, zinc, umirolimus (also known as biolimus A9) or a sensitivity to contrast media, which cannot be adequately pre-medicated 10. PCI during the previous 6 months for a stable lesion other than the target lesion of the index procedure OR PCI during the previous 12 months for a ACS lesion other than the target lesion of the index procedure 11. Participation in another clinical trial (up to 12 months after index procedure) 12. Patients with a life expectancy of less than 1 year

研究者

发起方
Department of Cardiology, Osaka Police Hospital

相似试验

Vascular healing after the BioFreedom drug coated... | 临床试验